ZETIA (EZETIMIBE) ANTITRUST LITIGATION

CASE NO. 18-MD-02836 (E.D. VA.)

LGN represents end payor plaintiffs who purchased, paid for, and/or provided reimbursement for Zetia, a blockbuster cholesterol drug that counteracts plaque development in arteries. This action is pending in the United States District Court for the District of Virginia before the Honorable Rebecca Beach Smith.